VISUDYNE PHOTODYNAMIC THERAPY FOR THE TREATMENT OF WET MACULAR DEGENERATION

Photodynamic Therapy (PDT) is a new treatment available for Wet Age Related Macular Degeneration (AMD)  According to the American Academy of Ophthalmology, Visudyne is the first drug of its kind to be approved for the treatment of wet AMD.  The wet for of AMD-the type for which Visudyne has been approved is a great threat to vision.  In the wet form of the disease, new blood vessels grow beneath the retina where they leak fluid and blood and can create a large blind spot in the visual center.  The Food and Drug Administration approved the drug Visudyne, a photosensitizer to be used in the treatment process of select patients with well-defined forms of AMD.  This treatment is an outpatient procedure, in which the drug is injected over a ten-minute period into the arm.  the drug then concentrates in the abnormal blood vessels, and sealing off the leakage without damaging the surrounding area.  Repeat treatments are usually needed to maximize efficacy of the process.

With PDT, vision may be preserved and, in some cases improved, for patients with wet AMD.

For further information contact our office at (801)399-1149, and ask for Melody, and/or A Visudyne hotline is available at 1-800-821-2450, or visit their website www.visudyne.com

FOR INFORMATION REGARDING THE CHEC PHYSICIAN SPECIALIZING IN VISUDYNE PHOTODYNAMIC THERAPY